Fibrosarcoma Chemotherapy Treatment to reach close to US$ 200 million revenue by 2026 end
Fibrosarcoma has no definite cause like other sarcomas. However, most of the sarcomas are associated with the genetic mutations. Soft tissue fibrosarcoma is among rare [read full press release…]